Table 1 General characteristics of study participants1
|  | Placebo (n = 30) | Vitamin D 2(n = 30) | Omega-33 (n = 30) | Vitamin D+ omega-34 (n = 30) | P5 |
|---|---|---|---|---|---|
Age (y) | 29.2 ± 3.4 | 29.9 ± 5.0 | 29.7 ± 3.6 | 29.9 ± 4.0 | 0.869 |
Height (cm) | 161.6 ± 4.8 | 161.5 ± 4.1 | 161.5 ± 3.4 | 161.8 ± 3.7 | 0.985 |
Weight at study baseline (kg) | 75.1 ± 7.7 | 76.1 ± 12.7 | 74.3 ± 5.8 | 77.4 ± 10.2 | 0.632 |
Weight at end-of-trial (kg) | 77.5 ± 7.7 | 78.6 ± 12.5 | 76.7 ± 6.1 | 80.0 ± 10.0 | 0.559 |
Weight change (kg) | 2.3 ± 0.7 | 2.5 ± 1.1 | 2.4 ± 0.5 | 2.6 ± 0.6 | 0.570 |
BMI at study baseline (kg/m2) | 28.8 ± 3.4 | 29.2 ± 5.0 | 28.5 ± 2.4 | 29.5 ± 3.8 | 0.746 |
BMI at end-of-trial (kg/m2) | 29.7 ± 3.4 | 30.1 ± 4.8 | 29.4 ± 2.5 | 30.5 ± 3.7 | 0.683 |
BMI change (kg/m2) | 0.9 ± 0.3 | 1.0 ± 0.4 | 0.9 ± 0.2 | 1.0 ± 0.2 | 0.592 |